Skip to main content

Table 1 Demographic data of study population

From: Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: a pilot study

  Controls (N = 8) Diabetics (N = 6)
Age, years (range) 44 (28 – 59) 57 (42 – 71)*
BMI, kg/m2 25.7 ± 3.4 30.7 ± 9.4
Duration of diabetes (year) - 7.7 ± 5
Fasting blood glucose (mmol/l) 4.9 ± 0.4 8.5 ± 1.5*
HbA1c (%) 5.4 ± 0.2 6.8 ± 0.8*
Total cholesterol (mmol/l) 5.1 ± 0.8 3.7 ± 0.3*
LDL cholesterol (mmol/l) 3.1 ± 0.7 1.8 ± 0.3*
HDL cholesterol (mmol/l) 1.3 ± 0.5 1.2 ± 0.4
Triglycerides (mmol/l) 1.4 ± 0.8 2.5 ± 2.9
Creatinine (μmol/l) 83 ± 12 69 ± 10
Urea (mmol/l) 5.5 ± 0.8 5.0 ± 0.9
Oral antidiabetic therapy (nr of patients)   
 Metformin   4
 Glimepiride   3
 Exenatide   1
 Gliclazide   1
 Liraglutide   1
 Pioglitazone   1
  1. BMI: body mass index; LDL: low-density lipoprotein; HDL: high-density lipoprotein. Data are represented as mean ± SD unless indicated otherwise; Mann–Whitney U test, * p < 0.05.